Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 13.9% of Vishay Intertechnology Inc.'s common stock.

BlackRock, Inc. has filed an amendment to disclose its beneficial ownership of 8.8% of XPO, Inc.'s common stock, totaling 10,418,923 shares as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing beneficial ownership of 11.9% of Capri Holdings Ltd's common stock as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, reporting a 2.0% beneficial ownership stake in iRobot Corporation's common stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, revealing a 6.1% beneficial ownership stake in Solid Biosciences Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 9.6% beneficial ownership stake in Sprouts Farmers Market Inc. as of June 30, 2025.

BlackRock, Inc. has reported a beneficial ownership of 5.2% of Synchronoss Technologies Inc.'s common stock, totaling 598,757 shares, as of June 30, 2025.

BlackRock, Inc. has reported a 5.8% beneficial ownership stake in Beauty Health Co's Class A Stock, held for passive investment purposes as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 17.2% of Urban Edge Properties' common stock as of June 30, 2025.

BlackRock, Inc. has reported a 5.6% beneficial ownership stake in Weave Communications, Inc. common stock, held for investment purposes.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 14.6% beneficial ownership stake in Xerox Holdings Corp as of June 30, 2025.

BlackRock, Inc. has reported a 14.6% beneficial ownership stake in ABM Industries Inc., holding over 9 million shares of common stock.

BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 6.5% in aTYR Pharma Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has reported an increased beneficial ownership of 17.0% in Acadia Realty Trust, holding over 22.2 million common shares.

BlackRock, Inc. has filed an updated Schedule 13G, reporting a beneficial ownership of 17.2% of American States Water Company's common stock as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, disclosing a beneficial ownership of 15.8% of ARMOUR RESIDENTIAL REIT INC's common stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 17.1% of California Water Service Group's common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 11.0% in Topgolf Callaway Brands Corp., totaling 20,274,023 common shares as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in The Eastern Company's common stock as of June 30, 2025.

BlackRock, Inc. has reported a 2.1% beneficial ownership stake in Full House Resorts Inc., holding 759,625 common shares as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, revealing a 6.0% beneficial ownership stake in Genie Energy Ltd.'s Class B Stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.7% in Genuine Parts Company as of June 30, 2025.

BlackRock, Inc. has reported a beneficial ownership of 6.7% of GEVO INC's common stock, holding 16,004,547 shares as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 17 to its Schedule 13G, disclosing a 9.3% beneficial ownership stake in Interpublic Group of Companies Inc., totaling 34,509,287 shares.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 1.5% beneficial ownership stake in Jasper Therapeutics Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.9% passive beneficial ownership stake in KKR & Co. Inc.'s Class A Stock as of June 30, 2025.

BlackRock, Inc. has increased its beneficial ownership in Medical Properties Trust Inc. to 13.1% of common stock, holding over 78 million shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 1.9% of Ocugen, Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.2% beneficial ownership stake in ORIC PHARMACEUTICALS INC as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 9.3% beneficial ownership stake in Prologis, Inc. as of June 30, 2025.